From mouse genetics to systems biology by unknown
COMMENTARY
From mouse genetics to systems biology
Rudi Balling
Received: 11 June 2007 / Accepted: 11 June 2007 / Published online: 1 August 2007
 Springer Science+Business Media, LLC 2007
Introduction
It will not be long before we have mutant alleles for every
gene in the mouse genome. It also will not be long before
we can sequence an entire genome in a few hours and for
less than 1000 US$. But there is much more to come, and
the speed with which these developments will take place
will surprise you. Imagine following the fate of every
single cell during the development of a mouse from fer-
tilization to birth and even beyond. Imagine watching the
expression of a single molecule of any protein or the total
expression of all proteins in a single cell continuously over
time. Imagine titrating the expression of single genes in
specific cell populations at will.
High-throughput technologies have become the driving
force in the analysis of biological systems. Biologists are
increasingly taking advantage of automatization, minia-
turization, and computerization. In this sense biology fol-
lows the development of computer and information
technology: smaller size, higher speed and capacity, lower
cost. However, we should remember that the age of com-
puter and information technology was preceded by a pre-
exponential phase during which important theoretical
frameworks and concepts were developed: Alan Turing
(1936) and John von Neumann (1945) provided the
mathematical basis for an automatic computing machine
and a corresponding ‘‘computer architecture.’’ To Claude
E. Shannon (Weaver and Shannon 1949) and Norbert
Wiener (1948) we owe the mathematical theory of infor-
mation and cybernetics. The convergence of electronic and
mechanical engineering then triggered the development
and application of systems control theory, a key require-
ment for the modeling and simulation of the dynamics of
technical systems.
A major challenge in biology is to model, simulate, and
eventually predict the behavior of complex biological
systems. The identification of the individual components
that constitute a biological system, i.e., through the gen-
ome-wide transcriptome, proteome, and metabolome
analysis, will be required but will not be sufficient to
achieve this goal. We will also need detailed information
about the ‘‘network architecture’’ and the dynamics of
biological systems. This is where systems biology comes
into place (Kitano 2002; Kirschner 2005; Palsson 2006;
Alon 2007).
From perturbation to model building: an iterative cycle
in systems biology
Biological systems are emerging, adaptive systems, highly
complex and often nonlinear. Their behavior cannot be
explained solely on the basis of their individual parts. Deep
insight into the network structure, function, and dynamics
of biological systems can be obtained only through their
systematic perturbation, followed by a detailed character-
ization of the molecular, cellular, and phenotypic changes
that follow these perturbations. Based on the perturbation
consequences observed, a model can then be established or
existing models modified or further developed that grasp
the important features of the underlying mechanisms
(Sauro and Kholodenko 2004).
Mouse genetics has been an extremely powerful per-
turbation method for nearly a century. Loss-of-function and
gain-of-function mouse mutants are able to reveal causal
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relationships between specific genes and specific pheno-
types. An impressive mouse genetics toolbox is now
available that allows us to perturb a wide range of bio-
logical systems. Methods such as the production of trans-
genic mice, gene targeting through homologous
recombination in embryonic stem (ES) cells, phenotype or
gene-driven mutagenesis strategies, or RNAi-based
knockdown are now used on a routine basis. Sequence
diversity is also a form of natural perturbation. In combi-
nation with the analysis of gene expression and phenotype
analysis, a thorough comparison of the consequences of
allelic variants can be very powerful. The main challenge
will be the functional dissection of the combinatorial
activity of small sequence changes, forming the core of
‘‘Complex Trait Analysis.’’
Perturbing biological systems through genetic changes is
only one way to obtain information to dissect the structure
and function of genetic networks. Equally important and
increasingly appreciated is the use of small molecules, which
can act as agonists or antagonists of biological processes
(Schreiber 2005). Whereas a while ago combinatorial
chemistry was largely a domain of pharmaceutical drug
development, the power of small molecules as a means to
study the function of specific proteins or pathways is
increasingly appreciated. There are specific strengths and
weaknesses to the use of small molecules. One of the most
important aspects is specificity. Very rarely does a small
molecule bind to one and only one target; in many cases the
precise number and nature of targets is unknown. Small
molecules are more adaptable to the titration of dose-re-
sponse or pulse-chase studies. Similar to searching for
modifiers in a genetic screen, chemical biologists now are
starting to perform combinatorial screens to unravel redun-
dancies or pathway interactions that are not revealed by
single small-molecule screens. In fact, one may be able to
stay below the ‘‘toxic window’’ of a specific small molecule
by combining two or more of them, each of which acts on
different targets within the same pathway. Eventually we
will see a convergence between the fields of small molecules
and small animals, i.e., in the area of noninvasive imaging
(Sako 2006). Molecular markers will become available that
allow us to follow perturbations at the molecular and cellular
level and in real time.
A need for integrative network analysis
Analyzing the individual components of a network is not
sufficient. We need to understand how these components
interact with each other and which are in direct or indirect
contact. We must know how the components dynamically
interact, what compensatory mechanisms are triggered, and
when components are defective or are inactivated. An
understanding of a system therefore requires knowledge
about the system’s structure and architecture (Papin et al.
2005). Once we have sufficient information about the
structure of a system, we can begin to study systems
dynamics. This will then help us to understand the control
measures that are responsible for the overall behavior of
the system or its modules under external perturbations
(Carpenter and Sabatini 2004; Barabasi and Zoltva 2004;
Alon 2007). These cannot automatically be inferred from
the parts list of a system. Biological information is passed
through a number of highly integrated networks, including
transcriptome, proteome, or metabolome networks
(Khammash and El-Samad 2004; Saez-Rodriguez et al.
2004). Methods to reconstruct or analyze biological net-
works have become an active field of research (Oda et al.
2005; Oda and Kitano 2006). Since Leonard Euler and Paul
Erdo¨z, the field of network analysis and graph theory has
developed tremendously. Network analysis is also the basis
of understanding disease pathogenesis and disease traits.
Modules: Making sense out of black boxes
A common theme in advanced technologies and engi-
neering is to divide systems into modules that can be
treated individually or in terms of connecting different
modules as part of a higher-order system. Since the dis-
covery of the double-helix structure of DNA, a reductionist
approach to analyze biological systems has proved to be
extremely successful. However, we feel that we are
reaching a limit as to how much we can learn about
complex biological systems by looking with increasing
resolution at individual components of a system. No doubt,
at the end we would like to understand biological phe-
nomena on the basis of atomic resolution. On the other
hand, the rise of systems biology reflects our increased
appreciation and desire of looking at all the scales of
biology, including the molecular, cellular, organismic, and
population-based levels.
Partitioning biological systems into modules helps to
achieve a more integrated picture. To understand causal
relations among individual parts and modules, we need
information about the directionality of flow of information
or material between the edges within a network (Natarajan
et al. 2006). We already know that systems behave dif-
ferently depending on whether we deal with one or a few
molecules or millions of molecules. Stochastic and statis-
tical approaches, i.e., Bayesian network reconstruction
algorithms, need to be applied to deal with the uncertainties
and probabilities of biological systems (Needham et al.
2006). The role of noise in biological systems is just being
unraveled. Some of the most important contributions are
currently made by physicists who are able to apply the
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repertoire of statistical physics to biological problems (Rao
et al. 2002; Samoilov et al. 2005; Sprinzak and Elowitz
2005; Kussell et al. 2005; Alon 2007).
Given their complexity, a remarkable feature of biologi-
cal systems is their robustness with respect to environmental
perturbations (Kitano 2004a,b; Kitano and Oda 2006; Kurata
et al. 2006). How do biological systems preserve their
function despite environmental conditions that can differ
over magnitudes of scale leading to tremendous fluctuations
in metabolic components or ligands? We do not yet under-
stand the underlying mechanisms that are responsible for this
robustness. Genetic redundancy, i.e., the presence of multi-
gene families that can at least partially substitute for each
other, is apparently one way to increase the robustness of a
system. Similarly, a redundancy of pathways could con-
tribute to the potential of a cell to maintain the robustness of a
biological system. On the other hand, there might be a price
to be paid, i.e., under different environmental conditions,
leading to a tradeoff of robustness versus fragility dependent
on the external factors that act on the system (Kurata et al.
2006). Robustness or fragility of biological systems can be
understood only if we obtain insight into the structure and the
dynamics of elements responsible for feedback control, an
essential element in almost all complex systems (Schmidt
and Jacobsen 2004).
Systems biology and drug development
Robustness and fragility are also highly important on
understanding disease pathogenesis or the susceptibility or
resistance toward the development of diseases (Butcher et al.
2004; Kitano 2004b; Fishman and Porter 2005; Wagner
2005). What are the factors that drive a physiologic system
toward its disease state? How can we interfere with an
unbalanced situation through preventive or therapeutic
measures and maybe push back a disease state toward a more
buffered state? What are the critical components that could
be selected as a drug target? We are just at the beginning of
identifying specific molecular components as indicators of
the state of a system and more important as predictors for the
future development of the system, i.e., as an early marker for
disease development (Lage et al. 2007). These ‘‘biomarkers’’
do not necessarily need to be the same as those that qualify as
drug targets. One of the frustrating issues in the drug
development pipeline is the lack of sufficient preclinical
predictability for safety and efficacy. Although many of the
animal models are able to predict side effects of drug can-
didates, in many cases we miss adverse reactions and identify
them at later stages of clinical development. By combining
network analysis, statistics, and high-throughput genetic and
genomic approaches to identify new relevant biomarkers,
systems biology bears great potential to improve the pre-
dictability of our preclinical in vitro and vivo models (Hood
et al. 2004).
Look at the similarities and treasure the differences
Maybe we have focused too much on the similarities of
model organisms instead of also trying to understand the
differences. Maybe we should increase our efforts in com-
parative systems biology. We might have to take a much
closer look at the differences between mice and humans in
terms of their relevance for drug development and try to
understand the mechanisms of species-specific absorption,
distribution, metabolism and excretion (ADME). Some of
the species differences can be overcome by, for example,
introducing human genes into the mouse genome or by xe-
nografting human stem cells into mice (Shultz et al. 2007).
These efforts in ‘‘humanizing mice’’ are still at the ‘‘trial and
error’’ stage. We urgently need a comparative systems
analysis that could guide us in selecting the most relevant
genes or cell types that are the cause of differences in drug
responses or disease pathogenesis and that should be prior-
itized in our efforts to improve the predictability of mice as a
model system for human disease.
Biological systems are complex adaptive systems that
emerge during the development from a fertilized egg to the
development of an adult organism. During evolution
changes in the environment lead to different constraints
and fixation of certain degrees of freedom in genome
structure and function. Components of genome networks
can be added or changed only when the workability and
functionality of the biological system is maintained, at least
to a certain degree (Ottino 2004; Weitz et al. 2007).
Comparative systems analysis needs appropriate data-
bases (Albeck et al. 2006; Kersey and Apweiler 2006).
These are not yet sufficiently developed. The mouse
comparative ontology database (http://www.informat-
ics.jax.org/menus/homology_menu.shtml) is useful but
does not provide information about the components,
interactions, and dynamics of physiologic systems.
We need all the information available, i.e., a user–
friendly, easily retrievable information system on the level
of transcripts of a given cell, the dynamic response of
mouse vs. human cells to small molecules, the levels of
redundancy in the two species, species-specific genes,
splicing patterns, and post-translational modification.
A need for modeling and simulation
Networks of biological systems are so complex that they
cannot be understood by intuition. Some systems properties
are even counterintuitive! It is the iteration of experiment
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and simulation that will characterize future systems biol-
ogy. We need to describe biological systems mathemati-
cally and treat them in an integrated and quantitative
manner to come up with predictions about their behavior
(Gershenfeld 2006; Szallasi et al. 2006). So far biologists
often formulate their conceptional picture of a biological
system as a flowchart-type model. These are more or less
static and do not encompass information about the behavior
of a system over time, i.e., after a specific environmental
perturbation. Model building has often been done by
biologists on an intuitive basis. Biologists are often not
aware that there already exists a rich literature and toolbox
in systems control theory (Csete and Doyle 2002; Tyson
2003; Brent 2004). We need to get used to applying sys-
tematic perturbations, observing the reaction of the system
to these perturbations, developing a first-approximation
model, and testing this model by further perturbation
studies (Locke et al. 2005; Aldridge et al. 2006; Janes and
Yaffe 2006). Biologists are fairly well trained in hypothesis
testing but not in hypothesis generation. This is where
systems biology has its greatest potential. Description will
converge with prediction.
Do not be afraid of mathematics
Systems biology often tries to apply formal mathematical
descriptions based on time-series analysis of biological
response. So far the sheer amount and the quality of data
constituted significant roadblocks to tackle the dynamics of
biological systems. Technological advances help us to
overcome these problems. A more severe problem, at least
for the current generation of biologists, is the limited
training in mathematics. The first two years of engineering
training provides the mathematical toolbox necessary for a
mathematical description of technical systems and is
essential for modeling or simulating the behavior of com-
plex systems. It will be neither possible nor useful to turn
every biologist into a mathematician. However, we need to
improve the dialog between biologists and mathematicians,
physicists, and engineers. The basics of linear algebra,
vector analysis, and graph theory have to enter the cur-
riculum of a biologist’s training (Wingreen and Botstein
2006).
Unfortunately, formal tools for model production do not
yet exist. In addition, model building is not easy and re-
quires a very good understanding of the biological system
under study. A question often raised is where to start:
bottom up, top down, or a combination of both. An inter-
esting suggestion is to start ‘‘middle out,’’ where the
modeling begins at the level at which there are rich bio-
logical data and then reach up and down to other levels
(Noble 2002). Another major difficulty is the transfer of a
model from one application to another. We need to develop
standardization frameworks so that even novices in com-
putational biology or systems biology are able to build,
access, and work with existing models (Wall et al. 2004).
Complex trait analysis: the next frontier in systems
biology
For more than 100 years mouse genetics has relied on the
analysis of single monogenic mutants. The methods to
identify or produce mutants have changed considerably
over the years. Soon we will have in our catalogs and
freezers mouse mutants for every gene in the genome
(Collins et al. 2007). Extensive collections will also be
available as a result of phenotype-driven mutagenesis
screens (Balling 2001). Whereas the analysis of these
mutants might keep us busy for many years to come, the
next frontier of mouse genetics is already on the horizon:
systems genetics. We all know that the expressivity and
penetrance of mouse mutant phenotypes can vary tremen-
dously, depending on the genetic background. Modifier
screens can be used to identify some of the genetic loci
responsible for the strong influence of genetic background
on physiologic and pathophysiologic processes. Sequenc-
ing and, as a cheaper substitute, SNP typing have provided
us with a detailed picture of the genetic diversity of our
main inbred mouse strains. Most of them are derived from
a very limited pool of parental strains, and strong selection
was applied to obtain the handsome, highly adapted com-
mon lab strains of mice that we now use in our experi-
ments.
Recombinant inbred strains and other reference panels
of inbred strains are powerful tools for performing a gen-
ome-wide dissection of complex biological traits that are
the result of multiple, quantitative, and often highly inter-
acting genes (Churchill et al. 2004; Flint et al. 2005; Zou
et al. 2005; Hill et al. 2006; Peters et al. 2007). The series
of BXD strains has been a paradigm for the success of
analyzing complex traits. Unfortunately, the use of re-
combinant inbred strains does not fall under the category
‘‘quick and easy’’ but requires a fair amount of logistics,
infrastructure, and an appreciation for the power of
genetics. The major bottleneck, however, was the ‘‘power
of mapping resolution’’ that the analysis of 30-80 re-
combinant inbred strains provides. The Complex Trait
Consortium has tackled precisely this problem (Churchill
et al. 2004). The goal is to produce approximately 1000
recombinant inbred strains (The Collaborative Cross)
within the next five years and make them available as an
open source to the scientific community. Importantly, the
parental strains chosen include three strains that we would
classify as ‘‘inbred wild mice,’’ i.e., PWK/PhJ, WSB/EiJ,
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and CAST/EiJ. The inclusion of these genetically highly
diverse strains adds about 75% additional sequence diver-
sity. The availability of this large panel of diverse and well-
structured strains will allow experiments where mice with
an identical genotype can be produced in large numbers
and compared to an equally large number of mice with a
wide range of different genetic and even environmental
backgrounds. Sequencing of the parental strains and a
community-based complementary and additive phenotyp-
ing will eventually produce a resource that will help us to
answer questions about gene function, epistatic genetic
interactions, and genome-environment interactions that we
can currently only dream about.
There are other approaches, i.e., the development of
consomic mouse strains, that essentially target the same
questions (Peters et al. 2007). It will be important to not look
at these approaches as exclusive or competitive, but as a new
toolbox of quantitative trait analysis where each one has
specific pros and cons. New phenotyping methods, including
gene expression arrays, or phenotyping based on noninva-
sive imaging will have to be integrated into the described
complex trait studies. Microarrays are a new micropheno-
typing platform that allow us to look at the expression of
thousands and hundreds of thousands of different genes
(eQTLs). This shift to microphenotypes requires new sta-
tistical tools because of multiple-testing issues but it also
gives a much higher computational capacity then ever be-
fore. To quote Denis Noble: ‘‘Biology is set to become highly
quantitative in the 21st century. It will become a computer-
intensive discipline’’ (Noble 2002).
For many years mouse genetics has been the driving
force as a hypothesis generator for functional genomics.
Mouse models, i.e., transgenic mice, knockout mice, or
mouse mutants identified from phenotype-driven screens,
are great tools to identify candidates for human disease
genes. The construction of mouse inbred strain panels de-
rived from genetically diverse parental populations pro-
vides us with valuable model populations. At the same
time, the power of human association studies has reached a
point where some people even think that it heralds the end
of mouse genetics. I think the opposite is true. The avail-
ability of mouse reference populations will allow us to ask
questions that complement those addressed by human
association studies. More importantly, we can quickly
validate hypotheses derived from human population studies
not only by constructing equivalent mouse populations but
also by probing the function of individual genes through
the analysis of gene targeting or specific point mutation
alleles. The argument that we can find such mutations also
in human populations does not take into account that in
mice we are not only able to study the effect of genetic
variation, but also to ‘‘titrate the environment’’ much better
than it will ever be possible for humans.
At this time, mouse geneticists and human geneticists
have not connected well enough to exploit the power of
their respective toolboxes. To quote Rob Williamson:
‘‘There is still an impedance mismatch between human
association and reductionist mouse studies.’’ Maybe this
special issue of Mammalian Genome can contribute to
better cooperation between mouse and human geneticists.
It will pay off for all of us.
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